233 related articles for article (PubMed ID: 37514116)
1.
Udu-Ituma S; Adélaïde J; Le TK; Omabe K; Finetti P; Paris C; Guille A; Bertucci F; Birnbaum D; Rocchi P; Chaffanet M
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514116
[TBL] [Abstract][Full Text] [Related]
2. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.
Zhang X; Mu X; Huang O; Xie Z; Jiang M; Geng M; Shen K
PLoS One; 2013; 8(8):e72053. PubMed ID: 23991038
[TBL] [Abstract][Full Text] [Related]
3. High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer.
Reynisdottir I; Arason A; Einarsdottir BO; Gunnarsson H; Staaf J; Vallon-Christersson J; Jonsson G; Ringnér M; Agnarsson BA; Olafsdottir K; Fagerholm R; Einarsdottir T; Johannesdottir G; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Cancer Med; 2013 Aug; 2(4):437-46. PubMed ID: 24156016
[TBL] [Abstract][Full Text] [Related]
4. ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
Sircoulomb F; Nicolas N; Ferrari A; Finetti P; Bekhouche I; Rousselet E; Lonigro A; Adélaïde J; Baudelet E; Esteyriès S; Wicinski J; Audebert S; Charafe-Jauffret E; Jacquemier J; Lopez M; Borg JP; Sotiriou C; Popovici C; Bertucci F; Birnbaum D; Chaffanet M; Ginestier C
EMBO Mol Med; 2011 Mar; 3(3):153-66. PubMed ID: 21328542
[TBL] [Abstract][Full Text] [Related]
5. ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes.
Klæstad E; Sawicka JE; Engstrøm MJ; Ytterhus B; Valla M; Bofin AM
Breast Cancer Res Treat; 2021 Feb; 186(1):65-77. PubMed ID: 33389351
[TBL] [Abstract][Full Text] [Related]
6.
Mollashahee-Kohkan F; Saravani R; Khalili T; Galavi H; Sargazi S
Rep Biochem Mol Biol; 2019 Jul; 8(2):119-125. PubMed ID: 31832434
[TBL] [Abstract][Full Text] [Related]
7. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.
Holland DG; Burleigh A; Git A; Goldgraben MA; Perez-Mancera PA; Chin SF; Hurtado A; Bruna A; Ali HR; Greenwood W; Dunning MJ; Samarajiwa S; Menon S; Rueda OM; Lynch AG; McKinney S; Ellis IO; Eaves CJ; Carroll JS; Curtis C; Aparicio S; Caldas C
EMBO Mol Med; 2011 Mar; 3(3):167-80. PubMed ID: 21337521
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA H19 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Breast Cancer Cells by Targeting miR-491-5p/ZNF703 Axis.
Wang Y; Wu Z; Li Y; Zheng Z; Yan J; Tian S; Han L
Cancer Manag Res; 2020; 12():9247-9258. PubMed ID: 33061615
[TBL] [Abstract][Full Text] [Related]
9. Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors.
Bazarov AV; Yaswen P
Breast Cancer Res; 2011 May; 13(3):308. PubMed ID: 21635707
[TBL] [Abstract][Full Text] [Related]
10. ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.
Zhang X; Mu X; Huang O; Wang Z; Chen J; Chen D; Wang G
BMC Cancer; 2022 Mar; 22(1):226. PubMed ID: 35236318
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of ZNF 703 in breast cancer tissue: An opportunity for RNAi-NSAID combinatorial therapy.
Marzbany M; Bishayee A; Rasekhian M
Biotechnol Appl Biochem; 2019 Sep; 66(5):808-814. PubMed ID: 31195426
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells.
Pescatori S; Leone S; Cipolletti M; Bartoloni S; di Masi A; Acconcia F
J Exp Clin Cancer Res; 2022 Apr; 41(1):141. PubMed ID: 35418303
[TBL] [Abstract][Full Text] [Related]
13. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
14. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
15. microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study.
Amiruddin A; Massi MN; Islam AA; Patellongi I; Pratama MY; Sutandyo N; Natzir R; Hatta M; Md Latar NH; Wahid S
Ann Med Surg (Lond); 2022 Jan; 73():103092. PubMed ID: 35079352
[TBL] [Abstract][Full Text] [Related]
16. ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.
Wang S; Wang C; Hu Y; Li X; Jin S; Liu O; Gou R; Zhuang Y; Guo Q; Nie X; Zhu L; Liu J; Lin B
J Exp Clin Cancer Res; 2020 Nov; 39(1):264. PubMed ID: 33246486
[TBL] [Abstract][Full Text] [Related]
17. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
Creighton CJ; Fu X; Hennessy BT; Casa AJ; Zhang Y; Gonzalez-Angulo AM; Lluch A; Gray JW; Brown PH; Hilsenbeck SG; Osborne CK; Mills GB; Lee AV; Schiff R
Breast Cancer Res; 2010; 12(3):R40. PubMed ID: 20569503
[TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis.
Lu C; Yang Y; Lingmei L; Qiujuan H; Qianru G; Lisha Q; Wenfeng C; Yun N; Peisen Z
Breast Cancer Res Treat; 2023 Jan; 197(1):71-82. PubMed ID: 36334189
[TBL] [Abstract][Full Text] [Related]
19. A novel selective estrogen receptor degrader induces cell cycle arrest in breast cancer via ERα degradation and the autophagy-lysosome pathway.
Zhou J; Shen R; Liu J; Deng X; Xin L; Zhou HB; Huang J
Bioorg Med Chem; 2023 Mar; 82():117235. PubMed ID: 36905762
[TBL] [Abstract][Full Text] [Related]
20. Acquired Tamoxifen Resistance in MCF-7 Breast Cancer Cells Requires Hyperactivation of eIF4F-Mediated Translation.
Fagan DH; Fettig LM; Avdulov S; Beckwith H; Peterson MS; Ho YY; Wang F; Polunovsky VA; Yee D
Horm Cancer; 2017 Aug; 8(4):219-229. PubMed ID: 28577281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
